Nomura Asset Management International »

Monte Rosa Therapeutics shares owned by Nomura Asset Management International

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Nomura Asset Management International from 13F filings

Historical chart of Nomura Asset Management International investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Nomura Asset Management International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Nomura Asset Management International

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.3M 200k 16.45

More positions owned by Nomura Asset Management International

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Amazon (AMZN)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Seagate Technology Hldngs Pl Ord Shs (STX)
Howmet Aerospace (HWM)
Advanced Micro Devices (AMD)
Visa Com Cl A (V)
Gilead Sciences (GILD)
Netflix (NFLX)
Mastercard Incorporated Cl A (MA)

View all positions for Nomura Asset Management International

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BlackRock
TCG Crossover Management
BVF
Baker Bros. Advisors
Suvretta Capital Management
Vestal Point Capital
State Street Corporation
Vanguard Group
Braidwell
Versant Venture Management
Vanguard Capital Management
American Century Companies
Silverarc Capital Management
Aisling Capital Management

View all funds holding Monte Rosa Therapeutics